SARS-CoV-话题@MedSci

#SARS-CoV#

221篇内容 | 3643人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1938018, encodeId=1a171938018b2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Gut：入院时肝功能异常与SARS-CoV-2感染严重病程相关, objectType=article, longId=213079, objectId=11082130e9fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11082130e9fe, replyNumber=0, likeNumber=68, createdTime=2021-09-11, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11082130e9fe, moduleTitle=Gut：入院时肝功能异常与SARS-CoV-2感染严重病程相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11082130e9fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937999, encodeId=3078193e99948, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=GUT：英夫利昔单抗治疗IBD患者的抗SARS-CoV-2抗体反应减弱, objectType=article, longId=209005, objectId=ad36209005e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad36209005e9, replyNumber=0, likeNumber=65, createdTime=2022-01-26, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad36209005e9, moduleTitle=GUT：英夫利昔单抗治疗IBD患者的抗SARS-CoV-2抗体反应减弱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad36209005e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938012, encodeId=4d191938012a0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=BMJ：SARS-CoV-2急性期后4个月内后遗症发病风险很高, objectType=article, longId=211628, objectId=afe921162828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afe921162828, replyNumber=0, likeNumber=77, createdTime=2021-10-05, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afe921162828, moduleTitle=BMJ：SARS-CoV-2急性期后4个月内后遗症发病风险很高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afe921162828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937956, encodeId=a150193e9569a, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=NAT COMMUN：神兽”的抗体果然神奇！研究发现，羊驼抗体能“绑定”在SARS-CoV-2上，有效阻止其感染宿主, objectType=article, longId=200489, objectId=482f2004893c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=482f2004893c, replyNumber=0, likeNumber=81, createdTime=2021-05-26, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=482f2004893c, moduleTitle=NAT COMMUN：神兽”的抗体果然神奇！研究发现，羊驼抗体能“绑定”在SARS-CoV-2上，有效阻止其感染宿主, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=482f2004893c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937978, encodeId=2847193e978c9, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Ann Neurol：SARS-CoV-2罕见并发症-小儿缺血性卒中, objectType=article, longId=204816, objectId=b7c420481630, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7c420481630, replyNumber=0, likeNumber=92, createdTime=2021-09-01, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7c420481630, moduleTitle=Ann Neurol：SARS-CoV-2罕见并发症-小儿缺血性卒中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7c420481630)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937977, encodeId=e459193e97703, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nature Neuroscience ：SARS-COV-2可穿过血脑屏障入侵大脑, objectType=article, longId=204680, objectId=7d3c2046805b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d3c2046805b, replyNumber=0, likeNumber=70, createdTime=2021-06-15, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d3c2046805b, moduleTitle=Nature Neuroscience ：SARS-COV-2可穿过血脑屏障入侵大脑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d3c2046805b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937996, encodeId=f7a9193e9964e, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=BMJ：儿童SARS-CoV-2血清流行的聚集性和纵向变化——对55所学校的前瞻性队列研究, objectType=article, longId=208682, objectId=98c7208682b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98c7208682b5, replyNumber=0, likeNumber=73, createdTime=2021-03-19, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98c7208682b5, moduleTitle=BMJ：儿童SARS-CoV-2血清流行的聚集性和纵向变化——对55所学校的前瞻性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98c7208682b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937976, encodeId=c8c1193e97653, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=J Clin Invest：新冠肺炎患者恢复期时体内抗SARS-CoV-2中和抗体的水平变化及相关因素, objectType=article, longId=204597, objectId=c42420459e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c42420459e0e, replyNumber=0, likeNumber=89, createdTime=2021-03-02, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c42420459e0e, moduleTitle=J Clin Invest：新冠肺炎患者恢复期时体内抗SARS-CoV-2中和抗体的水平变化及相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c42420459e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938001, encodeId=3b8f1938001e8, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=如何应对SARS-CoV-2加州变种？VIR-7831具有中和活性, objectType=article, longId=209636, objectId=3e3e209636c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e3e209636c8, replyNumber=0, likeNumber=74, createdTime=2021-11-25, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e3e209636c8, moduleTitle=如何应对SARS-CoV-2加州变种？VIR-7831具有中和活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e3e209636c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937988, encodeId=8326193e98819, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Gut：入院时肝功能检查异常与SARS-CoV-2感染严重病程相关, objectType=article, longId=206481, objectId=e3af20648105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3af20648105, replyNumber=0, likeNumber=74, createdTime=2021-04-04, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3af20648105, moduleTitle=Gut：入院时肝功能检查异常与SARS-CoV-2感染严重病程相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3af20648105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937963, encodeId=1c96193e9630b, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请, objectType=article, longId=201927, objectId=300020192e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=300020192e1c, replyNumber=0, likeNumber=75, createdTime=2020-10-21, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=300020192e1c, moduleTitle=辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=300020192e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938004, encodeId=a4fb19380049a, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=BMJ:Covid-19:我们对SARS-CoV-2的空气传播了解多少?, objectType=article, longId=210432, objectId=944b210432d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=944b210432d8, replyNumber=0, likeNumber=68, createdTime=2021-10-10, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=944b210432d8, moduleTitle=BMJ:Covid-19:我们对SARS-CoV-2的空气传播了解多少?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=944b210432d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937957, encodeId=6c40193e957a8, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JNNP：与SARS-CoV-2感染相关的Guillain-Barré综合征抗神经节苷脂抗体, objectType=article, longId=200508, objectId=107920050897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=107920050897, replyNumber=0, likeNumber=59, createdTime=2021-03-21, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=107920050897, moduleTitle=JNNP：与SARS-CoV-2感染相关的Guillain-Barré综合征抗神经节苷脂抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=107920050897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937979, encodeId=deed193e97996, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=柳叶刀-呼吸病学 | 通风不良的空间中的小飞沫气溶胶与SARS-CoV-2传播, objectType=article, longId=204807, objectId=60f120480ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f120480ebe, replyNumber=0, likeNumber=65, createdTime=2021-01-30, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f120480ebe, moduleTitle=柳叶刀-呼吸病学 | 通风不良的空间中的小飞沫气溶胶与SARS-CoV-2传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60f120480ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937943, encodeId=9559193e94306, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nat Commun：陶生策团队合作开发SARS-CoV-2蛋白质组芯片全局性分析新冠病人血清IgG&IgM应答, objectType=article, longId=198353, objectId=97fe198353d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97fe198353d2, replyNumber=0, likeNumber=69, createdTime=2020-08-07, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97fe198353d2, moduleTitle=Nat Commun：陶生策团队合作开发SARS-CoV-2蛋白质组芯片全局性分析新冠病人血清IgG&IgM应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97fe198353d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937962, encodeId=708e193e96274, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=君实生物重组全人源抗SARS-CoV-2单克隆抗体注射液进展良好, objectType=article, longId=201858, objectId=635420185860, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=635420185860, replyNumber=0, likeNumber=83, createdTime=2021-09-10, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=635420185860, moduleTitle=君实生物重组全人源抗SARS-CoV-2单克隆抗体注射液进展良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=635420185860)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937998, encodeId=fbf6193e99826, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JAMA：病毒变异后疫苗还有用吗？SARS-CoV-2感染和接种后的中和抗体检测, objectType=article, longId=208767, objectId=af15208e6794, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af15208e6794, replyNumber=0, likeNumber=52, createdTime=2021-06-11, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af15208e6794, moduleTitle=JAMA：病毒变异后疫苗还有用吗？SARS-CoV-2感染和接种后的中和抗体检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af15208e6794)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937982, encodeId=e87c193e982d5, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Br J Haematol :万万想不到，一名霍奇金淋巴瘤患者感染SARS-CoV-2后体内肿瘤竟然消退了, objectType=article, longId=205496, objectId=7e5b205496bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e5b205496bc, replyNumber=0, likeNumber=86, createdTime=2021-11-14, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e5b205496bc, moduleTitle=Br J Haematol :万万想不到，一名霍奇金淋巴瘤患者感染SARS-CoV-2后体内肿瘤竟然消退了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e5b205496bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937974, encodeId=e2ff193e97449, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nat Microbiol：口服药物MK-4482 / EIDD-2801或可阻止SARS-CoV-2传播, objectType=article, longId=204233, objectId=da092042334e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da092042334e, replyNumber=0, likeNumber=106, createdTime=2021-06-25, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da092042334e, moduleTitle=Nat Microbiol：口服药物MK-4482 / EIDD-2801或可阻止SARS-CoV-2传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da092042334e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937992, encodeId=2da5193e99266, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Lancet Global Health：人类感染SARS-CoV-2的血清学证据汇总, objectType=article, longId=208255, objectId=4eac20825510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eac20825510, replyNumber=0, likeNumber=72, createdTime=2021-03-31, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eac20825510, moduleTitle=Lancet Global Health：人类感染SARS-CoV-2的血清学证据汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eac20825510)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SARS-CoV

2020-05-29

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Gut：入院时肝功能异常与SARS-CoV-2感染严重病程相关

2021-09-11

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

GUT：英夫利昔单抗治疗IBD患者的抗SARS-CoV-2抗体反应减弱

2022-01-26

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

BMJ：SARS-CoV-2急性期后4个月内后遗症发病风险很高

2021-10-05

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

NAT COMMUN：神兽”的抗体果然神奇！研究发现，羊驼抗体能“绑定”在SARS-CoV-2上，有效阻止其感染宿主

2021-05-26

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Ann Neurol：SARS-CoV-2罕见并发症-小儿缺血性卒中

2021-09-01

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nature Neuroscience ：SARS-COV-2可穿过血脑屏障入侵大脑

2021-06-15

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

BMJ：儿童SARS-CoV-2血清流行的聚集性和纵向变化——对55所学校的前瞻性队列研究

2021-03-19

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

J Clin Invest：新冠肺炎患者恢复期时体内抗SARS-CoV-2中和抗体的水平变化及相关因素

2021-03-02

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

如何应对SARS-CoV-2加州变种？VIR-7831具有中和活性

2021-11-25

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Gut：入院时肝功能检查异常与SARS-CoV-2感染严重病程相关

2021-04-04

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请

2020-10-21

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

BMJ:Covid-19:我们对SARS-CoV-2的空气传播了解多少?

2021-10-10

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JNNP：与SARS-CoV-2感染相关的Guillain-Barré综合征抗神经节苷脂抗体

2021-03-21

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

柳叶刀-呼吸病学 | 通风不良的空间中的小飞沫气溶胶与SARS-CoV-2传播

2021-01-30

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nat Commun：陶生策团队合作开发SARS-CoV-2蛋白质组芯片全局性分析新冠病人血清IgG&IgM应答

2020-08-07

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

君实生物重组全人源抗SARS-CoV-2单克隆抗体注射液进展良好

2021-09-10

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JAMA：病毒变异后疫苗还有用吗？SARS-CoV-2感染和接种后的中和抗体检测

2021-06-11

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Br J Haematol :万万想不到，一名霍奇金淋巴瘤患者感染SARS-CoV-2后体内肿瘤竟然消退了

2021-11-14

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nat Microbiol：口服药物MK-4482 / EIDD-2801或可阻止SARS-CoV-2传播

2021-06-25

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Lancet Global Health：人类感染SARS-CoV-2的血清学证据汇总

2021-03-31

科室
- - 订阅+
  - 更多科室
工具
服务